SpyGlass Pharma IPO Closes, Raises $172.5M on Nasdaq SGP

ALISO VIEJO, Calif., USA - February 9, 2026 - SpyGlass Pharma, Inc. (Nasdaq: SGP), a late-stage biopharmaceutical company, today announced the successful closing of its initial public offering (IPO). The offering included the full exercise of the underwriters' option to purchase additional shares.

The company offered a total of 10,781,250 shares of its common stock at a public offering price of $16.00 per share. This figure includes the 1,406,250 additional shares purchased through the underwriters' option. The aggregate gross proceeds from the offering amounted to $172.5 million, before deducting underwriting discounts, commissions, and other associated expenses. All shares were offered directly by SpyGlass Pharma.

... Read on — Members only